Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. - Wikidata - awgldk - TriplyDB

Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.

Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.

http://www.wikidata.org/entity/Q34009168

about

The role of intensity modulated radiotherapy in gynecological radiotherapy: Present and future Hematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective.Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?A prospective phase II study of magnetic resonance imaging guided hematopoietical bone marrow-sparing intensity-modulated radiotherapy with concurrent chemotherapy for rectal cancer.Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer.Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer.A Phase II prospective nonrandomized trial of magnetic resonance imaging-guided hematopoietic bone marrow-sparing radiotherapy for gastric cancer patients with concurrent chemotherapy.Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data Cervical carcinoma following myelodysplastic syndrome: A case report.Technical aspects of radiation therapy for anal cancer.Bone marrow tolerance during postoperative chemotherapy in colorectal carcinomas.Fat composition changes in bone marrow during chemotherapy and radiation therapy.Association between bone marrow dosimetric parameters and acute hematologic toxicity in cervical cancer patients undergoing concurrent chemoradiotherapy: comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therap Dosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis.Radiation response of mesenchymal stem cells derived from bone marrow and human pluripotent stem cells.Bone marrow sparing in intensity modulated proton therapy for cervical cancer: Efficacy and robustness under range and setup uncertainties.Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer.Helical tomotherapy provides efficacy similar to that of intensity-modulated radiation therapy with dosimetric benefits for endometrial carcinoma.[(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients.Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy.Complications of pelvic radiation in patients treated for gynecologic malignancies.Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials.Adjuvant radiochemotherapy in patients with locally advanced high-risk cervical cancer.Longitudinal study of acute haematologic toxicity in cervical cancer patients treated with chemoradiotherapy.Dosimetric predictors of acute haematological toxicity in oesophageal cancer patients treated with neoadjuvant chemoradiotherapy Incorporating 18FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation.Lumbar-sacral bone marrow dose modeling for acute hematological toxicity in anal cancer patients treated with concurrent chemo-radiation.The Impact of Novel Radiation Treatment Techniques on Toxicity and Clinical Outcomes In Rectal Cancer.Dose to specific subregions of pelvic bone marrow defined with FDG-PET as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients.

P2860

Q26829528-4DDA9764-8B5C-41AB-A33C-63166811C4CC Q30235359-C2906101-CDC5-49A6-99AF-A2676BCEB231 Q33424898-BEBFC7EC-6067-41D2-A6D8-4B56949E06A6 Q33427911-07EB371B-44F6-4869-861E-ADDD34A78F77 Q33428648-8EC3711E-4FAC-41FA-A0FF-185B3042442B Q33431168-EA09BDAC-AA14-4B09-9B94-8897AF3F51B3 Q33432469-1C74A4A6-CB72-4BCB-9689-BCA3731C16EC Q33578833-B8AE45B3-CC3D-4420-BB04-777C418666F5 Q33778449-32D15153-523F-434B-88C7-41BDCE8CBDC5 Q33820797-2443D6FA-B5AF-4516-8728-6D645797370C Q33895624-2169C0EE-6865-4FC7-AE61-D7A6BE3B3104 Q34156572-B7830FE1-5B6B-4C10-9C02-5C429BB80B98 Q34434263-17A9A09F-9759-43E4-9CEB-E1A18BBEFD18 Q34487033-2434B742-2F24-4203-BBC3-A69CF8EFBF3A Q35234024-3953D583-4A75-4C2B-B9D8-B02B31D8B4F5 Q35868207-7ABA5B5E-B591-41A3-93E8-576C68F806B9 Q36067677-EF7CBA3D-8232-45A5-AD34-621D61D9E604 Q36296947-58C9961E-F90F-4363-9BE4-182C3251AA26 Q36609751-DBDFE4C2-60E7-4F7D-941A-467B9311735D Q36770157-869AEB95-D1F0-4D04-9A9B-4A7478E88F4E Q38233303-E28F4040-012D-49CC-9D07-490FE85FB67C Q38383439-F18FD181-3AAF-451C-9C51-3AA219F1DDF1 Q39614458-046085F3-4CB8-48CC-A3CD-F14C4DCF1357 Q41133417-9E8D4119-A0F3-494C-80A7-F61BA93DFF5D Q41635449-22D5469E-B0E2-49F8-B6FE-D5F6F40BE5EF Q44682134-33F7331F-E15A-4492-B9DA-00B57817CE17 Q48244052-781050A1-9245-44FC-B1E2-69F6A90FBE58 Q49531454-DE1E5450-C34C-4F7E-A800-6178A94CE9D7 Q51713174-1CE2F4A5-020D-4457-A57E-3D8E096E75CE

P2860

Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.

http://www.wikidata.org/entity/Q34009168

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Normal tissue complication pro ...... reated with chemoradiotherapy.

@ast

Normal tissue complication pro ...... reated with chemoradiotherapy.

@en

Normal tissue complication pro ...... reated with chemoradiotherapy.

@nl

type

label

Normal tissue complication pro ...... reated with chemoradiotherapy.

@ast

Normal tissue complication pro ...... reated with chemoradiotherapy.

@en

Normal tissue complication pro ...... reated with chemoradiotherapy.

@nl

prefLabel

Normal tissue complication pro ...... reated with chemoradiotherapy.

@ast

Normal tissue complication pro ...... reated with chemoradiotherapy.

@en

Normal tissue complication pro ...... reated with chemoradiotherapy.

@nl

P1433

Q34009168-41B49718-AAB4-4C1D-931E-80C134E9C148

P1476

Q34009168-D806424C-A4D2-4AB5-8843-DA47CD3B35EE

P2093

Q34009168-24FCE470-03A5-4EBF-8EBD-09861461D9D5

Q34009168-2E531169-6968-4970-91EC-710F706A1D44

Q34009168-474A948F-834B-498D-B922-8E47E02CF07B

Q34009168-85C8673F-5202-46D5-A339-9F02ECCF6687

Q34009168-A4FBF955-FDD9-4BE2-8B7F-1BAEC71FA482

Q34009168-C6E79244-A697-445A-9442-CEA0EC622087

Q34009168-DF726165-A75B-43F2-9130-CB2557A270E7

Q34009168-E4C6FF07-428C-4C52-AC49-C666EB0F2674

P2860

Q34009168-082BCFA1-6D70-4ED7-870B-F6F41FDE87D8

Q34009168-2B5A54BC-E09F-4510-B9B3-43C12E202065

Q34009168-2BEA4573-F82F-4037-8756-104A675B3DA8

Q34009168-32996086-CE76-49D0-9476-E576CEC77585

Q34009168-38F3F565-20BE-4790-8C6B-B012166528ED

Q34009168-3D96F37E-C4A1-4D8D-A972-BC89478D0F05

Q34009168-42A2A177-B466-4178-9D5A-C423D027E6F2

Q34009168-4A733E9A-6EDA-4CFB-A540-BC44896C0A31

Q34009168-54E99331-5A61-4F40-89C3-1C6F25246AEC

Q34009168-72D78B12-C55C-49D3-A783-9366C86B040A

P304

Q34009168-5A109AA9-800C-4C79-9DC7-89F9B4B80DED

P31

Q34009168-1D236BDF-473F-48C8-A6D6-1E4BDF335C81

P356

Q34009168-5006F1DF-71B6-4EED-9D5F-F35192DE4842

P407

Q34009168-1B14ABCA-BA24-48E8-81E5-3D794538E764

P433

Q34009168-BDDCC22B-FEE7-43E1-9A01-2D25D36D96D0

P478

Q34009168-2688CC06-4046-46E0-817E-10C2F13A7B66

P50

Q34009168-1257DD97-3CD3-426A-A7C2-CAD43E381792

Q34009168-B7E4992E-45F7-42DD-9E40-FD10956F8AFB

Q34009168-E8956F4D-F4F3-492F-85FE-D368E69DFAE7

P577

Q34009168-A7B4AD24-98C3-46A4-A0DA-A0236E3B1B2B

P5875

Q34009168-20475B77-FB1D-4523-AABA-F2788A59841E

P698

Q34009168-EDB77CB7-103B-486C-A583-E99F949613FF

P921

Q34009168-331DDDA7-800B-49A1-A119-128C8C8298E3

P932

Q34009168-11F47A1E-D1CA-404E-85EB-0353BC28EFD9

P356

J.IJROBP.2009.11.010

P1433

International Journal of Radiation Oncology Biology Physics

P1476

Normal tissue complication pro ...... treated with chemoradiotherapy

@en

P2093

Arno J Mundt

http://www.w3.org/2001/XMLSchema#string

Brent S Rose

http://www.w3.org/2001/XMLSchema#string

Bulent Aydogan

http://www.w3.org/2001/XMLSchema#string

Catheryn M Yashar

http://www.w3.org/2001/XMLSchema#string

Michael D Hasselle

http://www.w3.org/2001/XMLSchema#string

Rounak Bafana

http://www.w3.org/2001/XMLSchema#string

Virag Dandekar

http://www.w3.org/2001/XMLSchema#string

Yun Liang

http://www.w3.org/2001/XMLSchema#string

P2860

External beam radiotherapy and high-dose brachytherapy combined with cisplatin and paclitaxel in patients with advanced cervical carcinoma.

Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.

Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.

Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer.

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

Bone marrow imaging.

Bone marrow regeneration following large field radiation: influence of volume, age, dose, and time.

Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy.

Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies.

The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study.

P304

800-807

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJROBP.2009.11.010

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43182810

http://www.w3.org/2001/XMLSchema#string

P698

20400238

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

2907446

http://www.w3.org/2001/XMLSchema#string